치료용 침대 시장 : 제품 유형, 기술 유형, 요법 유형, 이용 환경, 최종사용자별 - 시장 예측(2026-2032년)

The Therapeutic Bed Market is projected to grow by USD 6.90 billion at a CAGR of 5.29% by 2032.

Therapeutic Bed Market Introduction

The therapeutic bed market is expanding as healthcare providers, long-term care operators, home healthcare agencies, and rehabilitation centers prioritize pressure injury prevention, patient mobility, infection control, and operational efficiency. Therapeutic beds include low-air-loss beds, air-fluidized beds, alternating-pressure mattresses, bariatric beds, critical care beds, and smart hospital beds designed to redistribute pressure, improve positioning, support wound care, and reduce caregiver burden.

Demand is underpinned by verifiable demographic and clinical drivers. The United Nations projects that people aged 65 and older will account for about one in six people globally by 2050, while the World Health Organization reported that more than 1 billion people were living with obesity in 2022. These trends increase the prevalence of immobility, chronic wounds, musculoskeletal disorders, and high-acuity care needs, making therapeutic support surfaces a strategic procurement category across hospitals and post-acute care settings.

For executives, the market opportunity is moving beyond basic bed replacement cycles. Buyers increasingly assess total cost of care, pressure injury reduction, interoperability with nurse call systems and electronic health records, ease of cleaning, energy efficiency, service uptime, and reimbursement alignment. Companies that combine clinical evidence, connected-bed functionality, and reliable after-sales support are best positioned to compete in a more outcomes-focused therapeutic bed industry.

Transformative Shifts in the Therapeutic Bed Landscape

The therapeutic bed landscape is being reshaped by the shift from reactive patient support to proactive, data-enabled care. Hospitals are standardizing pressure redistribution surfaces and advanced positioning systems to reduce hospital-acquired pressure injuries, a complication that the Agency for Healthcare Research and Quality has associated with significant morbidity, longer stays, and billions of dollars in annual U.S. treatment costs. This has elevated therapeutic beds from capital equipment to a measurable quality-of-care investment.

Post-acute and home care are also transforming demand. Shorter hospital stays, aging populations, and preference for care at home are increasing the use of medical beds in skilled nursing facilities, rehabilitation centers, hospice, and residential settings. At the same time, bariatric care requirements are pushing manufacturers to design higher weight-capacity frames, wider sleep decks, stronger motors, safer transfer systems, and more durable pressure management surfaces.

Supply-side competition is shifting toward modularity and connected platforms. Procurement teams increasingly favor beds that can be upgraded with sensors, patient exit alarms, integrated scales, bed-exit monitoring, pulmonary therapy functions, and digital maintenance diagnostics. Manufacturers that reduce lifecycle cost while improving clinical usability are gaining an advantage over suppliers competing mainly on unit price.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating a cumulative impact across therapeutic bed design, utilization, and service delivery. AI-enabled beds can support continuous monitoring of patient movement, bed-exit risk, moisture, weight change, and positioning patterns. When integrated with clinical workflows, these capabilities help caregivers prioritize turning schedules, identify fall risks, and intervene earlier for patients at risk of pressure injuries or respiratory complications.

AI is also improving asset utilization. Predictive maintenance algorithms can analyze motor performance, sensor behavior, and service histories to anticipate component failure and reduce bed downtime. For hospitals managing large fleets, better uptime and location visibility can reduce rental dependence, improve throughput, and support more accurate capital planning.

The most valuable AI applications will be those that are clinically validated, explainable, and privacy-conscious. Buyers will expect compliance with health data regulations, secure connectivity, cybersecurity controls, and transparent evidence that AI-driven alerts reduce alarm fatigue rather than add workflow burden. Vendors that pair AI with human-centered design and rigorous clinical validation will define the next generation of smart therapeutic beds.

Key Regional Insights Across Global Therapeutic Bed Markets

In Asia-Pacific, therapeutic bed demand is supported by hospital infrastructure expansion, aging populations in Japan, China, and South Korea, and rising chronic disease prevalence across India and Southeast Asia. Public and private hospital investments are creating opportunities for smart hospital beds, ICU beds, and cost-effective pressure relief surfaces tailored to high-volume care environments.

North America remains a high-value region due to advanced hospital networks, strong adoption of pressure injury prevention protocols, and established post-acute care infrastructure. The United States leads regional demand through hospital modernization, skilled nursing needs, bariatric care, and home healthcare growth, while Canada's publicly funded healthcare system supports procurement tied to safety, durability, and evidence-based outcomes.

Latin America is advancing as Brazil and Mexico expand hospital capacity, private healthcare access, and rehabilitation services, although procurement budgets vary widely by payer mix and public-sector funding cycles. Europe emphasizes quality standards, sustainability, and patient safety, with the European Union influencing procurement through medical device regulation, environmental objectives, and cross-border care expectations. In the Middle East, GCC hospital investments, specialty care expansion, and medical tourism initiatives support premium therapeutic bed adoption, while Africa presents long-term potential as healthcare infrastructure, critical care capacity, and international health funding continue to develop.

Key Group Insights for Therapeutic Bed Demand

ASEAN countries are gaining importance as hospital construction, urbanization, and rising healthcare expenditure increase demand for affordable therapeutic beds and pressure management surfaces. Procurement in this group often balances cost sensitivity with the need for durable, easy-to-maintain products suited to high patient volumes and varied infrastructure readiness.

The GCC represents a premium opportunity, driven by modernization of tertiary hospitals, specialty care centers, and medical tourism strategies. Buyers across the Gulf typically value advanced ICU beds, connected functionality, bariatric capability, infection-control design, and strong service coverage.

The European Union is shaped by strict medical device compliance, patient safety requirements, sustainability expectations, and harmonized regulatory oversight. BRICS markets offer scale, with China and India driving broad adoption, Brazil contributing regional demand in Latin America, Russia emphasizing localized procurement and health-system investment, and South Africa supporting African healthcare access. G7 markets lead in evidence-based procurement, smart therapeutic bed adoption, and lifecycle service models, while NATO countries emphasize resilient healthcare infrastructure, emergency preparedness, and interoperable medical assets for both civilian and contingency care settings.

Key Country Insights in the Therapeutic Bed Market

The United States is the most influential country market for therapeutic beds due to high healthcare spending, large hospital networks, skilled nursing demand, bariatric care requirements, and a strong focus on pressure injury prevention. Canada favors clinically proven and durable systems aligned with public healthcare procurement and provincial care standards, while Mexico is benefiting from private hospital expansion, cross-border medical care, and modernization of acute care facilities.

Brazil leads Latin American demand through its large healthcare system, expanding private hospital sector, and rehabilitation needs. In Europe, the United Kingdom prioritizes health-system capacity, patient safety, and long-term care needs; Germany benefits from advanced hospital infrastructure and engineering-led procurement; France focuses on quality care, reimbursement alignment, and aging-related care demand; Russia's market is influenced by domestic healthcare investment and procurement localization; Italy and Spain support demand through aging populations, rehabilitation services, and pressure injury prevention programs.

China is scaling hospital infrastructure and elderly care capacity, creating demand across value and premium segments. India is advancing through private hospitals, medical tourism, expanding critical care capacity, and growing chronic disease management needs. Japan has strong demand linked to one of the world's oldest populations and long-term care requirements, Australia supports adoption through high care standards, rehabilitation demand, and home healthcare services, and South Korea emphasizes technologically advanced hospital systems, digital health integration, and high-acuity care modernization.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically differentiated therapeutic beds that demonstrate measurable reductions in pressure injury risk, caregiver strain, fall events, and downtime. Evidence generation is essential: manufacturers should invest in real-world studies, health economic models, and outcome-based case studies that help procurement teams justify premium products through total cost-of-care savings.

Product strategy should focus on modular platforms that allow hospitals to upgrade from basic therapeutic support to connected monitoring, integrated scales, automated turning, bed-exit alerts, and predictive maintenance. Service capability is equally important; rapid repair, preventive maintenance, user training, and rental or leasing options can materially influence purchasing decisions.

Companies should also localize offerings by region. Premium smart beds may fit North America, the GCC, Japan, South Korea, Australia, and Western Europe, while durable, cost-efficient therapeutic surfaces and semi-electric beds may better serve emerging markets. Cybersecurity, regulatory compliance, cleaning efficiency, infection-control design, and sustainability should be treated as core product requirements rather than optional features.

Research Methodology

This executive summary is based on a structured secondary-research approach using publicly available and institutionally recognized sources, including health agencies, demographic databases, hospital quality literature, medical device regulatory frameworks, and healthcare infrastructure indicators. Key reference points include data and guidance from organizations such as the World Health Organization, United Nations, World Bank, Agency for Healthcare Research and Quality, and national healthcare authorities.

The methodology assesses demand drivers across clinical need, demographics, care settings, procurement behavior, technology adoption, and regional infrastructure maturity. Qualitative insights were triangulated across hospital modernization trends, pressure injury prevention priorities, aging and obesity data, post-acute care expansion, home healthcare adoption, and connected medical device integration.

Market conclusions are presented without unsupported revenue figures. Instead, the analysis emphasizes verified macro indicators, regulatory context, clinical burden, and purchasing factors that shape therapeutic bed adoption across hospitals, long-term care, rehabilitation, and home healthcare.

Conclusion

The therapeutic bed market is entering a more strategic phase as healthcare systems connect patient safety, clinical outcomes, caregiver efficiency, and asset management. Aging populations, obesity prevalence, chronic disease burden, and post-acute care growth are expanding the need for pressure redistribution, bariatric support, critical care positioning, rehabilitation support, and home-based therapeutic bed solutions.

Artificial intelligence and connected-bed platforms will increasingly define competitive advantage, but adoption will depend on clinical validation, secure interoperability, cybersecurity readiness, and workflow-friendly design. Regional opportunities will vary by infrastructure maturity and purchasing power, with North America, Europe, the GCC, and advanced Asia-Pacific markets leading premium adoption while emerging economies drive scalable demand.

Companies that align innovation with evidence, affordability, service reliability, regulatory compliance, and localized product design will be best positioned to capture growth in the global therapeutic bed industry.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Therapeutic Bed Market, by Product Type

• 7.1. Manual Therapeutic Beds
• 7.2. Semi-Electric Therapeutic Beds
• 7.3. Fully Electric Therapeutic Beds

8. Therapeutic Bed Market, by Technology Type

• 8.1. Connected Beds
• 8.2. Air Fluidized & Low Air Loss Beds
• 8.3. Kinetic Therapy Beds

9. Therapeutic Bed Market, by Therapy Type

• 9.1. Pressure Relief Therapy
• 9.2. Pulmonary Therapy
• 9.3. Critical Care Therapy
• 9.4. Rehabilitation Therapy

10. Therapeutic Bed Market, by Usage Setting

• 10.1. Acute Care
• 10.2. Chronic Care
• 10.3. Post-Surgical Care

11. Therapeutic Bed Market, by End User

• 11.1. Hospitals
• 11.2. Clinics
• 11.3. Home Healthcare Providers
• 11.4. Nursing Homes
• 11.5. Ambulatory Care Centers

12. Therapeutic Bed Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Therapeutic Bed Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Therapeutic Bed Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Concentration Analysis, 2025
  • 15.1.1. Concentration Ratio (CR)
  • 15.1.2. Herfindahl Hirschman Index (HHI)
• 15.2. Recent Developments & Impact Analysis, 2025
• 15.3. Product Portfolio Analysis, 2025
• 15.4. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Amico Group of Companies
• 16.2. Antano Group S.r.l.
• 16.3. Arjo AB
• 16.4. Baxter International Inc.
• 16.5. Besco Medical Limited
• 16.6. Drive DeVilbiss Healthcare
• 16.7. Gendron, Inc.
• 16.8. Getinge AB
• 16.9. GF Health Products, Inc.
• 16.10. Hard Manufacturing Company, Inc.
• 16.11. Hebei Pukang Medical Instruments Co., Ltd.
• 16.12. Invacare Corporation
• 16.13. Joerns Healthcare LLC
• 16.14. LINET Group SE
• 16.15. Malvestio S.p.A.
• 16.16. Medline Industries, LP
• 16.17. NOA Medical Industries, Inc.
• 16.18. Paramount Bed Holdings Co., Ltd.
• 16.19. PROMA REHA, s.r.o.
• 16.20. Savion Industries
• 16.21. Span-America Medical Systems, Inc.
• 16.22. Stiegelmeyer GmbH & Co. KG
• 16.23. Stryker Corporation
• 16.24. Transfer Master Products, Inc.
• 16.25. Zhangjiagang Medi Medical Equipment Co., Ltd.